Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-03-29 4:30 pm Purchase | 2024-03-25 | 13G | Q32 BIO INC QTTB | Carlyle Group Inc. CG | 1,102,741 9.200% | 1,102,741 (New Position) | Filing History |
| 2024-03-05 4:10 pm Sale | 2024-03-01 | 13D | THE CARLYLE GROUP INC. CG | Carlyle Group Management L.L.C. | 140,827,506 39.000% | -7,197,164 (-4.86%) | Filing History |
| 2024-02-13 4:55 pm Sale | 2023-12-29 | 13G | THE CARLYLE GROUP INC. CG | VANGUARD GROUP INC | 24,876,188 6.890% | -76,681 (-0.31%) | Filing History |
| 2024-02-12 6:00 pm Purchase | 2024-02-08 | 13D | JASPER THERAPEUTICS INC JSPR | Carlyle Group Inc. CG | 1,066,189 7.100% | 190,000 (+21.68%) | Filing History |
| 2024-02-12 5:46 pm Sale | 2023-12-31 | 13G | ZOOMINFO TECHNOLOGIES INC GTM | Carlyle Group Inc. CG | 35,244,474 9.000% | -1,417,995 (-3.87%) | Filing History |
| 2024-02-12 5:45 pm Sale | 2023-12-31 | 13G | MKS INC. MKSI | Carlyle Group Inc. CG | 0 0.000% | -8,482,732 (Position Closed) | Filing History |
| 2024-02-12 4:36 pm Purchase | 2023-12-31 | 13G | PHATHOM PHARMACEUTICALS INC CO PHAT | Carlyle Group Inc. CG | 3,496,808 6.100% | 561,702 (+19.14%) | Filing History |
| 2024-02-12 4:31 pm Unchanged | 2023-12-31 | 13G | HILLEVAX INC HLVX | Carlyle Group Inc. CG | 1,838,486 3.800% | 0 (Unchanged) | Filing History |
| 2024-02-12 11:22 am Sale | 2023-12-31 | 13G | THE CARLYLE GROUP INC. CG | MORGAN STANLEY MS | 10,485,962 2.900% | -12,926,684 (-55.21%) | Filing History |
| 2024-02-09 6:14 pm Purchase | 2024-02-07 | 13G | THE CARLYLE GROUP INC. CG | Capital World Investors | 20,008,088 5.500% | 17,791,088 (+802.48%) | Filing History |
| 2024-02-07 4:31 pm Purchase | 2024-01-25 | 13D | ADICET BIO INC ACET | Carlyle Group Inc. CG | 191,268 4.100% | 56,708 (+42.14%) | Filing History |
| 2024-01-25 1:48 pm Purchase | 2023-12-31 | 13G | THE CARLYLE GROUP INC. CG | BlackRock Inc. BLK | 31,155,048 8.600% | 31,155,048 (New Position) | Filing History |
| 2024-01-03 4:15 pm Purchase | 2023-12-31 | 13D | VISTANCE NETWORKS, INC. VISN | Carlyle Group Inc. CG | 42,257,593 16.600% | 2,789,051 (+7.07%) | Filing History |
| 2023-10-16 4:30 pm Purchase | 2023-10-12 | 13D | SOLENO THERAPEUTICS INC NE SLNO | Carlyle Group Inc. CG | 2,893,615 9.990% | 1,326,368 (+84.63%) | Filing History |
| 2023-10-03 4:05 pm Purchase | 2023-09-28 | 13D | SOLENO THERAPEUTICS INC NE SLNO | Carlyle Group Inc. CG | 1,567,247 9.990% | 339,930 (+27.70%) | Filing History |
| 2023-09-22 4:22 pm Purchase | 2023-07-28 | 13G | SUNPOWER INC SPWR | Carlyle Group Inc. CG | 2,745,879 5.700% | 2,745,879 (New Position) | Filing History |
| 2023-09-14 4:05 pm Purchase | 2023-09-12 | 13D | CARLYLE CREDIT INCOME FUND SHS CCIF | Carlyle Group Inc. CG | 4,785,628 41.000% | 1,269,537 (+36.11%) | Filing History |
| 2023-08-30 5:19 pm Purchase | 2023-08-28 | 13D | CARLYLE CREDIT INCOME FUND SHS CCIF | Carlyle Group Inc. CG | 3,516,091 33.800% | 2,672,060 (+316.58%) | Filing History |
| 2023-08-18 4:16 pm Unchanged | 2023-08-08 | 13D | EFFECTOR THERAPEUTICS INC EFTR | Carlyle Group Inc. CG | 193,196 7.800% | 0 (Unchanged) | Filing History |
| 2023-08-18 4:15 pm Purchase | 2023-08-08 | 13D | SOLENO THERAPEUTICS INC NE SLNO | Carlyle Group Inc. CG | 1,227,317 12.300% | 1,227,317 (New Position) | Filing History |